Ab interno implantation of glaucoma drainage devices tubes in the posterior chamber

Glaucoma drainage device (GDD) implantation is one of the most commonly performed surgical procedures for treating refractory glaucoma. However, GDD implantation is associated with complications, one of the most undesirable of which is long-term corneal decompensation. Corneal edema can result from multiple factors, but one is mechanical endothelial damage from the tubes in the anterior chamber. These tubes potentially can cause damage when they are near the cornea or in contact with the cornea during blinking, ocular movements, or eye rubbing, among others [1]. A proposed technique to move the tube away from the cornea requires tubal implantation into the vitreous cavity through the sulcus. However, this requires pars plana vitrectomy, which also has risks, especially if the vitreous must be removed completely [2]. Another possibility is tubal implantation into the posterior chamber between the iris and the intraocular lens in pseudophakic eyes. However, this technique is not always easy if the tube is inserted from outside the eye, because it may collide with the intraocular lens (IOL) or iris, be bent under the iris, or go into the vitreous.

We report an uncomplicated and straightforward procedure to implant a silicone tube in the posterior chamber in pseudophakic patients as an alternative to avoid tubal complications in the anterior chamber or vitreous.

A conjunctival peritomy is performed in a quadrant and the GDD plate is sutured 8 to 10 mm from the limbus as in the standard GDD implantation procedure. Initially, we recommend injecting hyaluronate into the posterior chamber to enlarge the chamber to facilitate movement of a 23-gauge needle in the posterior chamber. The new surgical technique of GDD tube implantation begins first with shortening the tube to an appropriate length to facilitate visualization through the pupil. (Fig. 1a). The length of the tube is calculated manually and is cut with scissors so that the bevel is - if possible- positioned somewhat laterally. One of the two needles at each end of a 9 or 10 Prolypropylene suture perforates the final part of the tube and is extracted, maintaining the suture through the tube. (Fig. 1b). A clear corneal incision is made on the opposite side from the site of the tubal implantation, and a 23-gauge needle is introduced through this incision into the anterior chamber, advanced into the posterior chamber, and passed through the sclera until the tip of the needle exits the eyeball (Fig. 1c). The two straight needles attached to the Prolene sutures are inserted into the lumen of the 23-gauge needle (Fig. 1e) and the 23-gauge needle (Fig. 1e) and the two needles are pulled out with the suture through the eyeball (Fig. 1f). The scleral incision that was created previously can be used to insert the tube and the sutures that pass through this incision. The tube then is simply inserted through the incision and the two Prolene sutures are pulled together to allow the tube to enter easily and be inserted into the posterior chamber (Fig. 1g). This traction of the Prolene sutures prevents the tube (when pushed only from the outside) from entering the vitreous cavity or from bending when there is friction between the iris or ciliary body. Once the tube is in place, one of the Prolene sutures is cut and removed from the eye by pulling it from either side (Fig. 1h). All patients provided informed consent before this surgery, which adhered to the Declaration of Helsinki.

We performed this procedure in 10 cases (Table 1) without complications. The GDD tubes were well positioned. In all the cases, a Baerveldt GDD was implanted. The end of the tube was seen at the periphery of the pupil without nearing the center of the cornea and without any optical effect. No particular intra-operative difficulties or complications such as bleeding, vitreous tube placement, bent tubes, etc. were observed. No iris damage or pigment dispersion was found. Finally, after the follow-up period (Table 1), no tube displacement or extrusion, or iris alteration were found. The endothelium data are not analysed for several reasons: the surgical technique is different (in some cases only the tube is implanted and in others phacoemulsification is also performed); some eyes were previously operated for glaucoma and others not; and the follow-up time is different in some cases than in others. However, no corneal edema was found after the follow-up period.

Tube shunts in the anterior chamber are associated with progressive endothelial cell loss [3]. Persistent corneal edema attributable to the GDD tube was reported to be almost 12% in the Ahmed Baerveldt Comparison Study after 5 years of follow-up [4]. Using anterior-segment optical coherence tomography, Tan et al. found that the tubal-corneal distance significantly affects the corneal endothelial cell density, i.e., the shorter the distance, the more severe the endothelial cell loss [5]. Therefore, maximization of the distance between the tube and the cornea is important, especially in eyes with other risk factors associated with endothelial damage but without performing a posterior vitrectomy. The current technique is easy to perform; the tube is inserted adequately behind the iris but remains visible through the pupil and is a safe distance from the cornea. We have performed other surgical approaches to insert the tube into the posterior chamber, but in our hands, the current technique is the simplest of all the approaches to achieve that end [6].

Our surgical procedure has other potential advantages in that it can be performed with different GDDs with a 23-gauge tube (Ahmed or Baerveldt), it can be performed simultaneously with cataract surgery or penetrating keratoplasty or Descemet membrane endothelial keratoplasty (DMEK), or to change the tube from the anterior to the posterior chamber in cases with rapid endothelial cell loss. The tube also is well positioned and avoids continuous rubbing against the iris, which can lead to reduced iris depigmentation or intraocular inflammation. The characteristics of this technique that distinguish it from other approaches are: first, the location of the tube is determined ab interno with the 23-gauge needle exiting the posterior chamber to the outside of the eyeball. The horizontal white-to-white distance and posterior chamber depth in pseudophakic eyes differ among patients, and there are anatomic variations [7]. This ab interno approach is similar to that previously described by Camejo et al. [8]. However our technique differs in the method of introducing the tube; these authors introduce it by pushing the tube [8]. In our technique the tube is pulled with the suture from inside the eye, which eliminates the tendency of the tube to enter the vitreous cavity; it also prevents the flexible tube from bending when obstructing the ciliary body, IOLor iris. A disadvantage is the additional cost of the Prolene sutures for this surgical approach.

This surgical procedure is easy to perform and it facilitates insertion and movement of the flexible tube into the posterior chamber. The procedure can be performed with all GDD implantations; it is not time-consuming and is safer for the endothelium than anterior chamber tube implantation. Although we did not experience complications in these 10 cases, a study that includes more patients and surgeons is required to determine the safety of this innovative surgical approach.